Extracellular NAD
Journal
Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179
Informations de publication
Date de publication:
14 Aug 2024
14 Aug 2024
Historique:
received:
30
12
2023
accepted:
31
07
2024
medline:
15
8
2024
pubmed:
15
8
2024
entrez:
14
8
2024
Statut:
epublish
Résumé
Liver fibrosis progressing to cirrhosis is a major risk factor for liver cancer, impacting surgical treatment and survival. Our study focuses on the role of extracellular nicotinamide adenine dinucleotide (eNAD
Identifiants
pubmed: 39143151
doi: 10.1038/s42003-024-06661-0
pii: 10.1038/s42003-024-06661-0
doi:
Substances chimiques
NAD
0U46U6E8UK
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
991Subventions
Organisme : Else Kröner-Fresenius-Stiftung (Else Kroner-Fresenius Foundation)
ID : EKFS, 2020_EKTP29
Informations de copyright
© 2024. The Author(s).
Références
Younossi, Z. M., Wong, G., Anstee, Q. M. & Henry, L. The Global Burden of Liver Disease. Clin. Gastroenterol. Hepatol. 21, 1978–1991 (2023).
pubmed: 37121527
doi: 10.1016/j.cgh.2023.04.015
Llovet, J. M. et al. Molecular pathogenesis and systemic therapies for hepatocellular carcinoma. Nat. Cancer 3, 386–401 (2022).
pubmed: 35484418
pmcid: 9060366
doi: 10.1038/s43018-022-00357-2
Krenzien, F. et al. Treatment of Intrahepatic Cholangiocarcinoma-A Multidisciplinary Approach. Cancers (Basel) 14, 362 (2022).
pubmed: 35053523
doi: 10.3390/cancers14020362
Ciria, R. et al. A systematic review and meta-analysis comparing the short- and long-term outcomes for laparoscopic and open liver resections for liver metastases from colorectal cancer. Surg. Endosc. 34, 349–360 (2020).
pubmed: 30989374
doi: 10.1007/s00464-019-06774-2
Rumgay, H. et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J. Hepatol. 77, 1598–1606 (2022).
pubmed: 36208844
pmcid: 9670241
doi: 10.1016/j.jhep.2022.08.021
Stockmann, M. et al. Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. Ann. Surg. 250, 119–125 (2009).
pubmed: 19561474
doi: 10.1097/SLA.0b013e3181ad85b5
Heil, J. & Schadde, E. Simultaneous portal and hepatic vein embolization before major liver resection. Langenbecks Arch. Surg. 406, 1295–1305 (2021).
pubmed: 32839889
doi: 10.1007/s00423-020-01960-6
Trammell, S. A. J. & Brenner, C. Targeted, Lcms-Based Metabolomics For Quantitative Measurement Of Nad+ Metabolites. Comput Struct. Biotechnol. J. 4, e201301012 (2013).
pubmed: 24688693
pmcid: 3962138
doi: 10.5936/csbj.201301012
Peluso, A. A., Damgaard, M. V., Mori, M. A. S. & Treebak, J. T. Age-Dependent Decline of NAD+—Universal Truth or Confounded Consensus? Nutrients. 14, 101 (2021).
pubmed: 35010977
pmcid: 8747183
doi: 10.3390/nu14010101
Zhu, X. H., Lu, M., Lee, B. Y., Ugurbil, K. & Chen, W. In vivo NAD assay reveals the intracellular NAD contents and redox state in healthy human brain and their age dependences. Proc. Natl Acad. Sci. USA 112, 2876–2881 (2015).
pubmed: 25730862
pmcid: 4352772
doi: 10.1073/pnas.1417921112
Massudi, H. et al. Age-Associated Changes In Oxidative Stress and NAD+ Metabolism In Human Tissue. PLoS One 7, e42357 (2012).
pubmed: 22848760
pmcid: 3407129
doi: 10.1371/journal.pone.0042357
Zhou, C. C. et al. Hepatic NAD(+) deficiency as a therapeutic target for non-alcoholic fatty liver disease in ageing. Br. J. Pharm. 173, 2352–2368 (2016).
doi: 10.1111/bph.13513
Jukarainen, S. et al. Obesity Is Associated With Low NAD+/SIRT Pathway Expression in Adipose Tissue of BMI-Discordant Monozygotic Twins. J. Clin. Endocrinol. Metab. 101, 275–283 (2016).
pubmed: 26574954
doi: 10.1210/jc.2015-3095
Poljsak, B. & Milisav, I. NAD+ as the Link Between Oxidative Stress, Inflammation, Caloric Restriction, Exercise, DNA Repair, Longevity, and Health Span. Rejuvenation Res. 19, 406–413 (2016).
pubmed: 26725653
doi: 10.1089/rej.2015.1767
Saqr, A. H. A. et al. Optimized protocol for quantification of extracellular nicotinamide adenine dinucleotide: evaluating clinical parameters and pre-analytical factors for translational research. Front. Med. (Lausanne) 10, 1278641 (2023).
pubmed: 38259852
doi: 10.3389/fmed.2023.1278641
Katsyuba, E., Romani, M., Hofer, D. & Auwerx, J. NAD+ homeostasis in health and disease. Nat. Metab. 2, 9–31 (2020).
pubmed: 32694684
doi: 10.1038/s42255-019-0161-5
Liu, L. et al. Quantitative Analysis of NAD Synthesis-Breakdown Fluxes. Cell Metab. 27, 1067–1080.e5 (2018).
pubmed: 29685734
pmcid: 5932087
doi: 10.1016/j.cmet.2018.03.018
Shibata, K. Organ Co-Relationship in Tryptophan Metabolism and Factors That Govern the Biosynthesis of Nicotinamide from Tryptophan. J. Nutr. Sci. Vitaminol. (Tokyo) 64, 90–98 (2018).
pubmed: 29710037
doi: 10.3177/jnsv.64.90
Haag, F. et al. Extracellular NAD and ATP: Partners in immune cell modulation. Purinergic Signal 3, 71–81 (2007).
pubmed: 18404420
pmcid: 2096762
doi: 10.1007/s11302-006-9038-7
Gasparrini, M., Sorci, L. & Raffaelli, N. Enzymology of extracellular NAD metabolism. Cell. Mol. Life Sci. 2021 78:7 78, 3317–3331 (2021).
Azouaoui, D. et al. Meta-analysis of NAD(P)(H) quantification results exhibits variability across mammalian tissues. Sci. Rep. 13, 2464 (2023).
pubmed: 36774401
pmcid: 9922293
doi: 10.1038/s41598-023-29607-8
Braidy, N., Villalva, M. D. & Grant, R. NADomics: Measuring NAD+ and Related Metabolites Using Liquid Chromatography Mass Spectrometry. Life (Basel) 11, 512 (2021).
pubmed: 34073099
Brunnbauer, P. et al. The nanomolar sensing of nicotinamide adenine dinucleotide in human plasma using a cycling assay in albumin modified simulated body fluids. Sci. Rep. 8, 16110 (2018).
pubmed: 30382125
pmcid: 6208386
doi: 10.1038/s41598-018-34350-6
Rahbari, N. N. et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149, 713–724 (2011).
pubmed: 21236455
doi: 10.1016/j.surg.2010.10.001
Govaere, O. et al. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis. Sci. Transl. Med 12, eaba4448 (2020).
pubmed: 33268509
doi: 10.1126/scitranslmed.aba4448
Mastellos, D. C., DeAngelis, R. A. & Lambris, J. D. Inducing and characterizing liver regeneration in mice: Reliable models, essential “readouts” and critical perspectives. Curr. Protoc. Mouse Biol. 3, 141 (2013).
pubmed: 24416636
pmcid: 3886822
doi: 10.1002/9780470942390.mo130087
Dall, M., Hassing, A. S. & Treebak, J. T. NAD+ and NAFLD - caution, causality and careful optimism. J. Physiol. 600, 1135–1154 (2022).
pubmed: 33932956
doi: 10.1113/JP280908
Guglielmi, A., Ruzzenente, A., Conci, S., Valdegamberi, A. & Iacono, C. How much remnant is enough in liver resection? Dig. Surg. 29, 6–17 (2012).
pubmed: 22441614
doi: 10.1159/000335713
Maegawa, F. B. et al. Association Between Noninvasive Fibrosis Markers and Postoperative Mortality After Hepatectomy for Hepatocellular Carcinoma. JAMA Netw. Open 2, e187142 (2019).
pubmed: 30657533
pmcid: 6484540
doi: 10.1001/jamanetworkopen.2018.7142
McCormack, L., Capitanich, P. & Quiñonez, E. Liver surgery in the presence of cirrhosis or steatosis: Is morbidity increased? Patient Saf. Surg. 2, 8 (2008).
pubmed: 18439273
pmcid: 2390525
doi: 10.1186/1754-9493-2-8
Kamarajah, S. K. Fibrosis score impacts survival following resection for hepatocellular carcinoma (HCC): A Surveillance, End Results and Epidemiology (SEER) database analysis. Asian J. Surg. 41, 551–561 (2018).
pubmed: 29454570
doi: 10.1016/j.asjsur.2018.01.001
Schreckenbach, T., Liese, J., Bechstein, W. O. & Moench, C. Posthepatectomy liver failure. Dig. Surg. 29, 79–85 (2012).
pubmed: 22441624
doi: 10.1159/000335741
Søreide, J. A. & Deshpande, R. Post hepatectomy liver failure (PHLF) - Recent advances in prevention and clinical management. Eur. J. Surg. Oncol. 47, 216–224 (2021).
pubmed: 32943278
doi: 10.1016/j.ejso.2020.09.001
Prodeau, M. et al. An ordinal model to predict the risk of symptomatic liver failure in patients with cirrhosis undergoing hepatectomy. J. Hepatol. 71, 920–929 (2019).
pubmed: 31203152
doi: 10.1016/j.jhep.2019.06.003
Kauffmann, R. & Fong, Y. Post-hepatectomy liver failure. Hepatobiliary Surg. Nutr. 3, 238–246 (2014).
pubmed: 25392835
pmcid: 4207837
Parker, R., Schmidt, M. S., Cain, O., Gunson, B. & Brenner, C. Nicotinamide Adenine Dinucleotide Metabolome Is Functionally Depressed in Patients Undergoing Liver Transplantation for Alcohol-Related Liver Disease. Hepatol. Commun. 4, 1183–1192 (2020).
pubmed: 32766477
pmcid: 7395074
doi: 10.1002/hep4.1530
Olthof, P. B. et al. Postoperative peak transaminases correlate with morbidity and mortality after liver resection. HPB (Oxf.) 18, 915–921 (2016).
doi: 10.1016/j.hpb.2016.07.016
Mpabanzi, L. et al. Surrogate endpoints in liver surgery related trials: a systematic review of the literature. HPB (Oxf.) 15, 327–336 (2013).
doi: 10.1111/j.1477-2574.2012.00590.x
Audrito, V., Messana, V. G., Brandimarte, L. & Deaglio, S. The Extracellular NADome Modulates Immune Responses. Front Immunol. 12, 704779 (2021).
pubmed: 34421911
pmcid: 8371318
doi: 10.3389/fimmu.2021.704779
Vassanasiri, W. et al. Early postoperative serum aspartate aminotransferase for prediction of post-hepatectomy liver failure. Perioperative Med. 11, 51 (2022).
doi: 10.1186/s13741-022-00283-y
McGill, M. R. The past and present of serum aminotransferases and the future of liver injury biomarkers. EXCLI J. 15, 817 (2016).
pubmed: 28337112
pmcid: 5318690
Giannini, E. G., Testa, R. & Savarino, V. Liver enzyme alteration: a guide for clinicians. CMAJ 172, 367–379 (2005).
pubmed: 15684121
pmcid: 545762
doi: 10.1503/cmaj.1040752
Willard, M. D. & Twedt, D. C. Gastrointestinal, Pancreatic, and Hepatic Disorders. Small Animal Clinical Diagnosis by Laboratory Methods 191–225. https://doi.org/10.1016/B978-1-4377-0657-4.00009-0 . (2012).
Hopp, A. K., Grüter, P. & Hottiger, M. O. Regulation of Glucose Metabolism by NAD+ and ADP-Ribosylation. Cells 8, 890 (2019).
pubmed: 31412683
pmcid: 6721828
doi: 10.3390/cells8080890
Rongvaux, A. et al. Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. https://doi.org/10.1002/1521-4141 . (2022).
Revollo, J. R., Grimm, A. A. & Imai, S. I. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J. Biol. Chem. 279, 50754–50763 (2004).
pubmed: 15381699
doi: 10.1074/jbc.M408388200
Kitani, T., Okuno, S. & Fujisawa, H. Growth phase-dependent changes in the subcellular localization of pre-B-cell colony-enhancing factor. FEBS Lett. 544, 74–78 (2003).
pubmed: 12782293
doi: 10.1016/S0014-5793(03)00476-9
Li, Y. et al. Extracellular Nampt promotes macrophage survival via a nonenzymatic interleukin-6/STAT3 signaling mechanism. J. Biol. Chem. 283, 34833–34843 (2008).
pubmed: 18945671
pmcid: 2596403
doi: 10.1074/jbc.M805866200
Revollo, J. R. et al. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab. 6, 363–375 (2007).
pubmed: 17983582
pmcid: 2098698
doi: 10.1016/j.cmet.2007.09.003
Liu, Y., Beyer, A. & Aebersold, R. On the Dependency of Cellular Protein Levels on mRNA Abundance. Cell 165, 535–550 (2016).
pubmed: 27104977
doi: 10.1016/j.cell.2016.03.014
Koussounadis, A., Langdon, S. P., Um, I. H., Harrison, D. J. & Smith, V. A. Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system. Sci. Rep. 5, 10775 (2015).
pubmed: 26053859
pmcid: 4459080
doi: 10.1038/srep10775
Zhao, S. et al. The concentration of tumor necrosis factor-α determines its protective or damaging effect on liver injury by regulating Yap activity. Cell Death Dis. 11, 70 (2020).
pubmed: 31988281
pmcid: 6985193
doi: 10.1038/s41419-020-2264-z
Sambeat, A. et al. Endogenous nicotinamide riboside metabolism protects against diet-induced liver damage. Nat. Commun. 10, 4291 (2019).
pubmed: 31541116
pmcid: 6754455
doi: 10.1038/s41467-019-12262-x
Gariani, K. et al. Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice. Hepatology 63, 1190–1204 (2016).
pubmed: 26404765
doi: 10.1002/hep.28245
Kamali, C. et al. Extended liver resection in mice: state of the art and pitfalls-a systematic review. Eur. J. Med. Res. 26, 6 (2021).
pubmed: 33422147
pmcid: 7797144
doi: 10.1186/s40001-020-00478-3
Cantó, C., Menzies, K. J. & Auwerx, J. NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus. Cell Metab. 22, 31–53 (2015).
pubmed: 26118927
pmcid: 4487780
doi: 10.1016/j.cmet.2015.05.023
Pauta, M. et al. Impaired liver regeneration in Ldlr-/- mice is associated with an altered hepatic profile of cytokines, growth factors, and lipids. J. Hepatol. 59, 731–737 (2013).
pubmed: 23712050
pmcid: 4145584
doi: 10.1016/j.jhep.2013.05.026
Xie, N. et al. NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential. Signal Transduct. Target. Ther. 5, 1–37 (2020).
von Elm, E. et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J. Clin. Epidemiol. 61, 344–349 (2008).
doi: 10.1016/j.jclinepi.2007.11.008
Schmelzle, M. et al. Robotic vs. laparoscopic liver surgery: a single-center analysis of 600 consecutive patients in 6 years. Surg. Endosc. 36, 5854–5862 (2022).
pubmed: 35641702
pmcid: 9283354
doi: 10.1007/s00464-021-08770-x
Benzing, C. et al. A tailored approach in lymph node-positive perihilar cholangiocarcinoma. Langenbecks Arch. Surg. 406, 1499–1509 (2021).
pubmed: 34075473
pmcid: 8370897
doi: 10.1007/s00423-021-02154-4
Brol, M. J., Drebber, U., Luetkens, J. A., Odenthal, M. & Trebicka, J. “The pathogenesis of hepatic fibrosis: basic facts and clinical challenges”—assessment of liver fibrosis: a narrative review. Dig. Med. Res. 5, 24–24 (2022).
doi: 10.21037/dmr-22-9
Arnold, A. et al. Analysis of NTRK expression in gastric and esophageal adenocarcinoma (AGE) with pan-TRK immunohistochemistry. Pathol. Res Pr. 215, 152662 (2019).
doi: 10.1016/j.prp.2019.152662
Fedchenko, N. & Reifenrath, J. Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue-a review. https://doi.org/10.1186/s13000-014-0221-9 . (2014).
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M. & Altman, D. G. Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research. PLoS Biol. 8, e1000412 (2010).
pubmed: 20613859
pmcid: 2893951
doi: 10.1371/journal.pbio.1000412